Hamish Mair
Fund Manager at CT PRIVATE EQUITY TRUST PLC
Replay available
Half-year investor update hosted by CT Private Equity Trust (LSE:CTPE) on Investor Meet Company, held 2025-09-03.

On 6ix: 6ix.com/event/ct-private-equity-trust-plc-ctpe-half-year-investor-update
Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.
0:01 Good morning and welcome to the CT PRIVATE EQUITY TRUST PLC Investor Presentation. Throughout this meeting, investors will be in listen only mode. Questions are encouraged and they can be submitted at any time by the Q and A tab situated in the right corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives in the meeting itself. However, the company can view the questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to fund manager, Hamish Meyer. Good morning to
0:31 you, sir. Good morning, and, thank you everybody for joining this webinar where I'm going to run through our interim results for the for the first six months of 2025. We have a presentation, which I will probably take about half an hour or so to run through, and then there should be plenty of time for questions after that.
0:59 Firstly, just take the opportunity to slightly blow our own trumpet. This is a list of the awards and achievements that we've had in the last twenty six years since the company was founded. Couple of recent ones. We are, top 20 best performing investment trust over ten years. In fact, we're ninth, over the last ten years. That's all investment trusts. And we're also what's known as the next generation investment trust dividend hero, which means that we've grown our dividend every year for ten years. You actually become a formal dividend hero if you've grown every year for twenty years. I think we've done about 13 or 14.
1:45 So, these are accolades we're quite proud of. So just going to the executive summary of the results. So the second quarter numbers, that's the the quarter to the end of June, showed a slight decline in the NAV down 1.8%. The portfolio itself is essentially flat. There's a bit of a negative exchange rate movement. And this quarter comes after another slightly down quarter in the first one when we're down 0.8%, which means we're down two and a half percent in the year so far. Couple of, words of caution before you start extrapolating that through into the rest of the year is that it's quite normal for the first couple of quarters of the year to be pretty quiet.
2:37 And often, the biggest determinant of the movement NAV is, in fact, movements in exchange rate. And this is because the June numbers are essentially composed of of marks that were made in March. Only about 10% of this valuation, would be actually up to date. June numbers is just to do with the timing of when we receive the, the valuations. And in March, the tends to be not that much change from the December numbers because the, the valuations are compiled literally a matter of a few weeks later. So, typically, first half is quite quiet unless there are, you know, large events in terms of realizations or, you know, significant change in the underlying performance of the company. So I don't think one should read too much into that at this stage.
3:31 A couple of things that are worth noting are that realizations in the second quarter of 16,800,000, which was just about the same as the new investment number. But if you look at the first half as a whole, realizations for £27,100,000, which is a bit less than the 31,200,000 of new investments. And the realization number is down by about half on the same period in 2024, and that's because the market in private equity has slowed significantly. Various reasons for that, but the main contributory factor was the uncertainty that has has come about as a result of the tariff situation in America, which is affecting everybody, including private equity.
4:29 Uncertainty is bad for private equity deal making because people don't quite know where they are, and they have to take time to reappraise. And the net effect of that is it's been harder to achieve realizations in the first half of the year. There still are quite a number, and I'll come on to talk about them in a minute, but they have, taken longer to achieve. There's quite a lot of things have been delayed, in some cases canceled, and in some cases, the price of those deals have come down. So that is the principal reason for this decrease in realizations. The dividend is... The quarter dividend, 7.01p. It's the same as it has been for the last few quarters. Just to remind you where the...
5:14 If the NAV goes flat or down or the average NAV goes flat or down, we maintain the dividend at the rate the rate it was paid previously. So it's a kind of upwards only dividend policy, and that's kicking in here. So we'll maintain the dividend at the current level, which gives a pretty attractive yield based on the on the share price. Co investments are about 40% of the portfolio. They... That is fractionally down where it was last quarter, but it's, you know, very similar to where it has been. A long term aim is to bring that up to about 50%. But, obviously, we keep selling things, which is a good thing, and we have to replace them. And so it's a a gradual process.
6:00 We we will get there, at some point fairly soon. So just looking at, this next slide, this just looks at the new investments that we've made so far this year. I'll talk about these in a little bit more detail in a minute. There's an IT services company in Finland called Friendy, which we have put just under €2,000,000 into that. We have also committed to a new Spanish mid market buyer fund called, we've also committed €10,000,000 to CastleMite Impact Partners, which as you can tell from the logo, is a fund that, we manage. This is a multi manager co investment fund with an impact mandate, and that is, has three different, themes that it addresses, environmental sustainability, equality and inclusion, and health and well-being.
6:59 And that is... The the key factor there is that each of the companies that find their way into that portfolio will have an impact on a sustainable development goal or one of the underlying targets, and we will measure and report on that impact. Everything else is, the same as you would find in a conventional fund, including the target rate of return. And this builds on the experience that we have in co investing and also in responsible investment. We're not... You know, the the trust is not charging a fee on those assets so that we don't we don't double fee on that. And neither is there a carried interest. So that is a, you know, a good deal for the investors and the trust, and it's obviously helpful to us to have them as an investor in the fund.
7:57 This is some of the recent exits. We're actually looking back about twelve months here. So a number of you probably heard of this one already. This is ATEC. It's an... It's a small insurance company that was a deal that was done by Kester Capital. This is a a broker and managing general agent. The lines of insurance that they're concerned with are are basically caravans, beach huts, small boats, quite a niche. And the business has been very much professionalized during Kester's tenure, which was about seven years. And they've made an excellent return, well over four times their money, and they've sort of quadrupled the the revenue and EBITDA over that period.
8:48 A lot of sort of digitalization going on, strengthening the the management. A really good out... Outturn here in what is quite a difficult sector or can be a difficult sector. Kester are a really good example of an emerging manager that we have backed early, which have really, you know, got into their stride in recent years and are delivering excellent returns. Amethyst radiotherapy is one that we have just just sold. So Amethyst is a chain of radiotherapy clinics right the way across Continental Europe, started in Eastern Europe, spread into Western Europe. Basically, what they do is they they use, you know, advanced forms of radiotherapy for the treatment of cancer.
9:39 This is an underserved market all the way across Europe. The radiotherapy is much more sophisticated now than it used to be, and it's basically the treatment of choice for cancer provided you have the machinery to administer it. These are these big line of machines that picture in the... You can see the pictures of those things, and they have a a good fleet of those across Europe. Business has grown significantly since we first invested in 2019. It was held back a bit during COVID, as you can imagine. Many things were. And the lead investor, the Manhattan Group, have sold it, and we've achieved 1.8 times cost and an 11% IRR.
10:29 Now this is a bit lower than ideally we would have liked, and this is an example of a deal where the sale process straddled all these events, creating uncertainty in the global economy, and that didn't help in terms of, of the sale process. There were a number of other factors. I think the choice of the adviser for the the sale, they chose Goldman's, and they were aiming to sell it to large private equity, and that was, you know, with the benefit of hindsight, possibly a little bit ambitious. And secondly, there was a kind of unhelpful shared... Shareholder dynamic where one of the founders had... Still had a big stake, had gone off to work for a competitor, and he had to be removed from the equity. So that, you know, didn't help in terms of price maximization.
11:20 However, it's a, you know, it's a perfectly respectable return. We've got £8,000,000 in, and it was sold to another mid market group called Fremen Capital who are are basically... It's a group composed of some partners who worked for PAI. So an okay result there. We also had an exit of of four portfolio holdings from the inflection portfolio, and these were actually sold to another vehicle run by inflection called inflection continuation fund. Now this is a way of actually achieving liquidity for your investors with investments that have been in the portfolio for a while, whether it's been good value creation, but whether it's still a good case to continue to hold.
12:15 But the whole horizon to maximize value is longer than the horizon of the funds in which they find themselves. So in other words, they... There... There's good growth to be had, but there's enough time, within the the current structure to do it. So they raise a new fund called the continuation fund with, different investors, although there will be some overlap with the current investor base. And, you can either cash out or you can roll over and, keep going. We've chosen to to cash out because the returns are excellent. The largest holding here is Aspen Pumps, which is over three times money. But there are three other companies, Rosemont, which is a liquid pharmaceuticals business where they made seven times money, Acorion, which is a, fund fiduciary services platform, nearly three times money there, and CNX, a specialty pharma platform, two times money.
13:16 So these are all, you know, good prices. And, you know, the pricing and everything is is verified by arm's length investors. And this is actually quite a common process, continuation funds where the manager continues to be, in charge, but there's a different, group of investors and a fresh structure is created. But we think it's perfectly okay. There are lots of advisory committees and people involved to make sure that it's a good deal for everyone, and that was the case here. Another sale, this was the sale of a remaining stake that we had in Dotmatics.
14:02 Dotmatics is a software company that provides software to the pharmaceutical and sort of academic sector. It's used in the development of new drugs. It allows scientists to share scientific information securely, between themselves even if they're, you know, other parts of the world. We actually already have realized most of this investment, in 2021. 88% of it was sold then, 12%, remained, and, that has now been sold. The total return on the investment, including the bit we sold before, is 8.4 times cost and nearly 80% IRR.
14:50 The last bit, the the 12% is is 4,700,000, which we're about to receive. So that's a great outcome. It was led by SEP, Scottish Equity Partners, which are, you know, one of the longest standing relationships we have. In fact, it dates back to 1996, and they are growth equity specialists. And this is a this is a great deal for them and for us. So those are the significant recent exits. This slide just shows you the progression of the NAV over the the long term. Obviously, it's flattened off a little bit recently, but the long term trend is still clearly positive.
15:39 This is another way of looking at the performance. You can see the share price and, NAV, total return performance massively outstripping the stock market, but there's a bit of gap between share price and, and NAV that should close itself is generally quite close. Although with these persistent discounts, that opportunity still remains to close that gap. This is just another way of looking at the different performances. On the last twelve months basis, you can see it has been... There's been limited progress. I mean, obviously, we've just had six months where it's gone down slightly. And last year itself was was a fairly small increase, and 2023 wasn't that punchy either.
16:36 We've been going through a period of transition in private equity with interest rates having gone up, and that has to work its way through the system. And, we've had this latest phase of uncertainty now. I would say that, at the beginning of the year, we felt that many of the ingredients for recovery were in place and that confidence was clearly picking up. We saw that in a significant pickup in realizations during 2024. But that has stalled a bit, in the first half. I mean, I think the, there's anecdotal evidence that things are beginning to pick up now. So we would hope that, the remainder of this year did produce much more significant progress. This is the outstanding undrawn commitments. We just show this as a matter of routine. These are completely normal at the moment at a 178,000,000, which is 37% of net assets, which is just below the five year average.
17:36 We do have to run with these commitments in order to be able to recycle the proceeds efficiently, and there's nothing to worry about there. In terms of debt, the debt is, just over a 100,000,000, slightly higher than I would have expected, but that's because of the slowdown in realizations. But we expect this to come down quite noticeably over the next few months as some other exits, kick in. And it's, you know, it's a perfectly manageable level here. We've got a lot of headroom still in our, borrowing facility. And, those of you who follow us closely will know that we do believe in the benefits of gearing. We tend to run with a geared portfolio because we expect that the returns that we'll make from investing in the portfolio are far in excess of the cost of borrowing, and that remains the case even now with higher costs of borrowing and and slightly lower rates of growth in the portfolio. But we firmly believe that that adds value for our shareholders. So we believe very much in running with a fully invested and mildly geared portfolio.
18:50 Just looking at some of the recent co investments, I mean, this this one was actually last year. I mean, I probably talked about this a few times before, but just recapping on accounts IQ. This is a software company that provides software for accounting for small and medium sized enterprises. The deal is led by Acxiom who are software specialists, and this is a bit like a, you know, more modern version of of Sage. Some of these smaller new companies can have an advantage over the large incumbents because they don't have they don't have lots of sort of legacy software all over the place. And this one has done well, continues to do well. We've also made a commitment the tail end of last year to inflection enterprise fund six. So inflection is a important relationship for for us, and they are... Oh, it's it's not exaggerating to say they are the sort of doyen of the lower mid market in The UK.
19:55 Very strong record. The enterprise fund is at the sort of bottom end of the size scale, in terms of the target enterprise value of companies, which is fifty to a hundred and fifty million pounds, which is where inflection, cut their teeth, and they're still very good at that activity. And so we had no hesitation in continuing to back them in that area. This is the, Finnish IT services company called Friendy, which we did earlier this year. This is a slightly unusual situation. I mean, first of all, we've known procuratas. They're a Nordic, buyout group for many years. And they, had... Have this holding in Friendly, is an IT services company in Finland, which is the thesis there has been to consolidate lots of little companies into medium sized company.
20:50 Most of the services they are providing to their customers are all about moving them to the cloud. That's that's a trend that's happening all the way across the Western economies, including in Finland. And in this investment, there there was... One of the original shareholders wanted an exit. The progress against the original business plan was was a bit behind plan. And so procuritas asked us if we would come in, but we have actually come in at a price which is below their original cost. So it's quite unusual. So we're getting in later at a lower price, and we'd expect to get our money back faster. So why did they ask us? You may ask, well, we've been close to them for a number of years. They know that we're an active co investor.
21:42 We know that... They know that we can move quickly and that even though it's a relatively small deal, it would be worth us doing. So they've they've brought us in. So we think this will be a short hold a couple of years perhaps, and we'll probably double our money in that time period. This is a new fund commitment to Spanish mid market buyer fund, Queka. Now we've been investing in in Spain, through funds and co investments for about twenty years, more than twenty years, actually. And we've had number of, partners there. A couple of them have sort of fallen by the wayside, if you like, and we were looking to find a fresh relationship there. And we've done quite a bit of work on Keka, and they... They're very experienced investors. Although this is a new fund or a new firm, the new fund.
22:40 But their sweet spot is in the lower mid market in Spain where there's a very rich seam of opportunities, and they have the sourcing ability, and they've also got the technical ability to make money there. So we were quite happy after quite a lot of due diligence to back them. So next page just shows you the significant realizations in this year to date. I mean, there are plenty. I know we are a bit down in terms of the overall quantum compared to this time last year, which was a pretty punchy year, but there's still a lot of different things happening. Companies being sold in different geographies by different houses and and generally achieving good returns.
23:30 So you can see them all going over. You know, it's a diverse portfolio. That's deliberate, and that is a strength in our view. We've also been rejuvenating the portfolio by new deals. Again, a range of different geographies, a range of different private equity houses and sectors, quite a variety. There's quite a strong technology component here in terms of software and and health care, and that is because about half our portfolio is invested in these areas. And I make no apology for that because that is reasonably typical for the private equity sector at the moment, and it is a function of the secular growth that is offered by these these sectors.
24:22 You know,
24:23 Software is becoming prevalent right the way across the economy. I think you'll all probably recognize that there are lots of applications, and these companies are creating and selling these applications all the way across Europe and further afield for different, niches.
24:46 And here's a few more that have come through. Mean, there are companies in here which are quite easy to understand. Like, Yard Sale Pizza is a pizza restaurant chain, so that's fairly self explanatory. You know? But others are, you know, are quite quite interesting and groundbreaking. ACCITARA is one here done by Vaca. They basically make robots that dispense medicine to people. So we're always talking about the benefits of technology that the NHS may reap in future years. Well, some countries are already doing this with, you know, robots that dispense medicine to people in their in their own homes.
25:37 So, you know, a lot of these new technologies, you might see them here first before you hear about them generally. This is the, distributions and drawdowns profile just here for information. I mean, there's clearly a a, relationship where if it's active on one side, it tends to be active on the other and vice versa. Obviously, we can control the co investment element quite precisely and the drawdowns and realizations from the funds. That's all a process of, you know, careful estimation looking forward. In terms of the largest underlying holdings, this hasn't changed, that dramatically. But just to highlight a couple of things to watch out for, WeirdFish, which is our clothing company where we hold 63% is actually performing very well.
26:31 We're probably gonna have a refinancing there to take some of the money off the table, but it's, it has done really, exceptionally well since the new chief executive was appointed about eighteen months ago, David Butler. The number two position is actually this helicopter company, OHI, and this is a business that's quite substantial. It's grown a lot. Sterling Square are the lead manager. I mean, they're quite keen to sell it, but they've struggled to exit it at what they regard as a acceptable price. It's based in Brazil. It services the offshore oil industry in Brazil, and that actually means, you know, that coupled with its size means that there are a limited number of of buyers.
27:21 And so it will take time to find the precise buyer there. But in the meantime, the business is actually trading very strongly. So, you know, we... We're quite happy to wait. Sigma is an electrical components company. I think I've probably mentioned this before. It was our largest holding. This is one of the few businesses in the portfolio where there is a direct exposure to the change in tariffs in America because they export from their factories in Mexico and India to The States. So they've obviously had increased tariffs put on them. However, their components are a small part of the end product, and they have passed on price increases to cope with the tariffs.
28:11 And these have stuck so far. Now it's difficult to tell what the long term impact will be. That that will, you know, that will take a little bit of time. So it appears not to be affecting the profitability of the business immediately. But what it has done is affected the ability of Argan to... The lead manager to sell it because that's quite a significant amount of uncertainty injected into the into the sort of decision making process. So that that will take longer to sell than we had thought, you know, wouldn't happen this year. It will happen next year or possibly later. The others are in reasonable shape, Utamaco, which makes these security tokens.
28:56 That's a growing market. That's been trading well. Hofi, that's otherwise known as San Siro. That is our funeral homes business. We've already sold three quarters of this. This is the quarter that we've got left, and that is... That's doing fine. TWMA is the processor of drill cuttings from oil rigs. Now this business has has shrunk a little. I mean, it's down about 10% year on year. It's a fairly difficult market, and they've moved quite a lot of their operations closer to where the mark... The main market is now, which is in The Middle East. But we we still aim to exit probably next year. Aurora payments is going well. It's still quite early days there.
29:42 Cyclomedia, which is the the street mapping software company is also going well. Amethyst, we've just sold actually, so that won't be in the list next time. And Breeze, which makes equipment for clean rooms is in reasonable shape. So the top 10 account for just 22% of the portfolio. So we've got a good spread, but these are the ones to watch out for because, you know, these can move the needle. In terms of the geography, it's not much changed. I mean, we've got 41% in The UK. We we like The UK market because we're based here, and it's the biggest deepest private equity in Europe by some measure.
30:29 We have more exposure to The UK than than our peers. I mean, most of them have got a few percent in The UK, mainly invested in America. We've got a little bit in America. Most of the rest is in Continental Europe, which is our sort of core market. In terms of age, about 60% is over three years old, 40% over four years old. Tip... The typical hold period is four or five years. So after about three years, if things have been going according to plan, they they will be planning an exit. So this is... You know, we monitor these three and four year old companies because it gives an indication of how much mature stock you've got coming through. Now we always have some coming through.
31:18 It does fluctuate a bit, but there's plenty of, you know, candidates for exit when the conditions are right. The average valuation across our co investments, is nearly half the portfolio is 10.9 times EBITDA, that's actually almost exactly the same as it is for the overall portfolio, which is 10.6 times.
31:43 And in terms of debt to EBITDA, the coinvestments are 2.7 times. It's not particularly highly geared. It's quite low, in fact. And that is... That compares to two and a half times for the overall portfolio. So the co investments, we we have immediate and easily available data on them. The overall portfolio takes a bit longer to compile that, but we do have that data. But the point is that the co investment portfolio is, you know, is fully representative of what we have in the overall portfolio, which is not a big surprise because they... We are investing
32:18 alongside the funds. On sector, as I mentioned earlier, health care and information technology, information technology is mainly software, but it also includes hardware. Health care is, you know, care and services in the care industry as well as life sciences, pharmaceuticals, medical devices. But if you take these two port... These two sectors together, they account for about half the portfolio. We've still got plenty in industrials, consumers, financials, and this gives us... You know, this this diversification is is a strength. As you probably heard me say before, I think the only way to handle the naturally high risk that you take on when investing in private equity is through having a diversified portfolio, and that provides resilience.
33:19 You can see throughout our twenty six year history that that has been a a great benefit to us. So to conclude, I mean, last year was a sort of year of stabilization and a bit of recovery with a big increase in realizations. This year,
33:42 the recovery, which we saw taking root in 2024, has been impacted. You know, it has stalled a bit, and that's because of the uncertainty that has been engendered. And it's obviously... We're not the only people that are affected by this. Everybody else is as well, but, you know, it's very clear in in the numbers. We think, you know, there are plenty of the ingredients for recovery are in place, but confidence and a more certain environment is a key one that, you know, has to has to occur before we'll get that recovery.
34:24 We see excellent deal flow for funds and co investments. I mean, there's been some really excellent propositions that we've seen recently. Obviously, we only take a very small proportion of those, and, you know, these will all lay the foundations for future growth. We've got a strong balance sheet. We've got plenty of resources, a really well diversified and resilient portfolio. And the underlying companies are in good growth mode. I mean, they're still growing their profits at about 20% per annum. Revenue is slightly less than that, but really good growth. And that will manifest itself in value in due course.
35:10 And so we are confident that the company will continue to grow value for shareholders over the short and longer term and very probably in the second half of this year.
35:22 So that is the... There are various appendices in here, but that's the end of the the presentation. So if people have got questions, I will do my best to answer them. Yes. Thanks, Hamish. I'll help out in that respect. My name is Peter Brown. I work, within the investment trust team at Columbia Threadneedle. We've had a couple of question... We have quite a few questions come in, and I'll please encourage you to submit more if you've got any to mind. We had a couple that, came from the AGM a couple of months ago. One's a bit technical. Why did the audit fee substantially increase from £75,000 to a £110,000? What's expected level of fees for the current year, please?
36:05 Yeah. The audit fee increased because audit fees are increasing across the board. Part of this is that they are required to do more work. The the sort of guidelines in terms of what the the level of scrutiny that they're expected to apply have changed a bit. I think for many years, fees were were, you know, surprisingly low. So our our audit fee went up from 70... Was it 73 up to a 110? You know, for a £500,000,000 company, that is not a particularly high fee. And I can tell you that when we were looking at other auditors, who are proposing fees, in every case, they were a lot higher.
36:55 So a 110 is is pretty good value. I mean, when I say a lot higher, I do mean a lot higher. We had... I think there was one quote where we were quoted about 300,000. So 110 from BDO, who are excellent firm. It's good. We wouldn't expect the fee to go up dramatically from here. It will will be more like a sort of inflationary increase from here. Thank you. You mentioned the discount on the trust. It's around 30%. The question is, does this make it vulnerable to us type activists?
37:32 Well, I mean, I think there's no room for complacency when you have a large discount to NAV. But there's quite a big difference between the private equity TRUST and other trusts that are invested largely in listed securities because an activist who will buy in at a discount and then subject the company to various pressure in order to, you know, get them to realize all their parts of the portfolio at or close to NAV
38:08 would be asking a private equity to come... Company to do something which is quite difficult. I mean, they, you know, they can't suddenly take control and then sell the entire portfolio just like that unless they are specialists in private equity. And even if they were, it would take them some time. So as I say, there's no room for complacency, but I think the the plan that, you know, an activist might have, which they may feel is relevant for an investment trust that's invested in the quoted market would probably be a completely impractical plan for the private equity market. Obviously, if, you know, it... They are private equity specialists or it's another private equity trust, you know, who's very familiar with the subject matter of the portfolio, the contents of the portfolio, then, you know, something could be done there.
39:02 But what we are doing is concentrating on trying to
39:05 reduce that discount by fundamental methods. In other words, encouraging more people to buy the shares than than sell them and to explain that there is there is real value here and that if you're a committed long term investor, you are likely to see that value. And, you know, for various reasons, the the whole sector has been languishing on a relatively wide discount for some time now.
39:30 You know, one of the arguments has been they don't believe evaluations. Well, I think that is demonstrably untrue because when we sell things, we sell them on average at a very significant premium to the previous carrying value. So even even in tougher periods such as the one that we've just had, I mean, the weighted average premium on our exits in the first half of this year, which was a sort of subdued period, was still, you know, low to mid teens above the previous carrying value. And in most years, it's, you know, it's more like 30% or better. So, you know, there are very good reasons to take advantage of the discount, you know, from a fundamental point of view.
40:21 Long term shareholder here asking a question. I've been in the trust for fifteen years, and I'm generally happy returns. However, the capital value has flatlined since September 22, and performance has lagged the AIC PRIVATE EQUITY index over one, three, five and ten years. What are your prospects for more regular profitable realizations, capital and income growth over the next period? Well, as I mentioned in my presentation, obviously, it has been a quiet period in the last couple of years. And I also think that now plenty of the ingredients for recovery are there. And if it wasn't for all this tariff nonsense, I think we'd have seen more of that, and we may well see that fairly soon once people have sort of processed the impact. In terms of the stats that
41:09 have been cited there, I think he's looking at the AIC private equity sector including three I. The three I is essentially a very concentrated portfolio with one company that's performed very strongly. So most people that are comparing performance against appears to exclude three I from the analysis. And if you do that, we are outperforming the sector over one, three, five, and ten years quite nicely. And you've seen the charts earlier where you've seen absolute outperformance of the long term. I mean, on the twenty six years since we've started, we've outperformed the stock market by about four and a half times. So,
41:54 you know, I think when we have these quiet periods, it's important to be patient, to see through that, to continue to invest, and hopefully reap the benefits as we return to a more typical rate of, growth, soon. Thank you. Could you explain the structural attractiveness of the small market compared to the large market in private equity? Why are the returns often better in the small market?
42:25 Yeah. The the the lower mid market buyout market that we invest in. So these are companies with an enterprise value of less than 500,000,000, and our sweet spot would be less than about 150,000,000. And why do we like that? Well, it's a very broad inefficient market, and therefore, a, you know, diligent and careful investor can buy well. In other words, they get in at lower prices Even though the gearing put into these deals is typically lower than it is for large deals, the returns are better. You know, this... Smaller companies can grow faster than bigger companies that are starting at a smaller base.
43:12 Most of the companies in our portfolio are niche businesses that are concentrating on one particular product or service, sometimes in one particular market, and they are only selected for private equity portfolios if they've got good strong growth characteristics. So you're getting essentially... We we are investing in a small subset of a small subset of of companies that private equity managers have found. I mean, across the continent of Europe, there are tens of thousands of businesses that are in the size bracket where private equity might be interested, but only a few 100 actually receive private equity every year. And these are the the ones with the best growth characteristics.
43:59 And that's one of the reasons that we outperform.
44:06 Okay. Sorry. Thank you. Next question. What are the most common reasons for removing a manager from the portfolio or, in other words, not reinvesting in the next fund? Do you find that managers try to run too much money? Yeah. I mean, the the most common reason is that they've failed to deliver either, you know, poor or lackluster performance. They've had too many deals that fall over.
44:34 Now we... We're typically not gonna invest in a fund unless we're pretty sure they can do a 20% net IRR. Now, you know, if they if they achieve 17 or 18%, we're not gonna get too upset about that. But if it turns out to be six or something, then that's, you know, that's obviously not good enough. We're taking all that risk, and we're not being rewarded for it. So, you know, we're always appraising how each of the funds that we invest in or the co investments, how they're doing
45:06 compared with what we expected when we invested. Sometimes people will try and raise too much money and therefore struggle to invest it wisely or sensibly. So that's one of the things we're always on the lookout for. If somebody has has done a fund at, you know, 200,000,000 and then the next fund they raise is 800,000,000, and it's a perfectly legitimate question. You know, how are you actually going to invest four times the money in the same time period as you have done before? If you start buying companies that are worth four times as much,
45:43 then that's a different part of the market to the one where you've made your track records. So these are the sort of discussions that we have all the time with with fund managers. And if we think they're being over ambitious or perhaps garnering more money than they can actually usefully deploy, then we will, we will hold back or we won't invest.
46:04 Thank you. Quite a direct question here from one of our viewers. Have we increased our holding in Northern Gritstone?
46:12 No. No. We have same position as we had when we went in a couple of years ago when it started. We have a £5,000,000 commitment to Northern Gritstone. So Northern Gritstone is the university spin out company for the universities of Manchester, Sheffield, Leeds, and now Liverpool. So it's full of really interesting early stage science oriented businesses. And I was at their annual meeting a few weeks ago, very upbeat. Lots to go for. It is a long term investment, so it will take time to show, you know, a lot of appreciation. But one of the reasons I actually made that investment is that wearing one of my other hats, I chair the investment committee of a fund called Old College Capital, which is the Edinburgh University spinout fund. And through that role, I I can see the potential of university spinouts. We've had some good exits there,
47:20 and I think, a similar kind of thing is gonna happen with the Northern Gritstone Fund. Well, funny enough, that ties in quite well with a question we've got, today. Do you come across any young companies that arise out of universities as spinoffs, And what is the health of university spin offs in this country?
47:38 There seems to be quite a few technological breakthroughs that hit the press, but do not... But these do not develop commercially. If you could expand that little. Yeah. No. That's right up my right up my street. I could speak for quite a few minutes or an hour or so on this subject, but there are there are lots of university spinouts. I mean, the Edinburgh portfolio that I've got direct experience of, we have... You know, it's probably about 70 companies altogether. These are generally too early stage to come into this portfolio because this is focused on management buyouts. They are all venture capital early or, you know, all early stage and vary from being seed stage to sort of series a or series b as they call it.
48:24 So they generally have a pretty high risk profile. So if we were to put them into this portfolio, we would have to have a portfolio within a portfolio because of the innately high risks involved. There are some amazing technologies coming through really exciting in terms of quite often health care and science. You know, I could talk for quite a long time about the various things that we've seen there. Also, ones that are connected to the environment and and climate change and some really sophisticated forms of software, a number of which are connected into AI.
49:10 So the university spinout sector in The UK is is strong, and it's getting stronger.
49:19 You know, in America, they've done this for longer and stronger there. But I think if you compare the British situation with what's happening elsewhere in Europe, it's significantly ahead ahead of them. I think there's a... You know, it's a really interesting sector.
49:37 Thank you. I'm gonna try and merge three questions, which is always never a clever idea. But, basically, the theme is about gilt yields, base rates, dislocation certainly in the moment between the two fiscal policy. How is CT PRIVATE EQUITY TRUST position... Positioning itself to mitigate the adverse impacts and capitalizing the investment opportunities? And I'm gonna merge this with, you remain optimistic in the short term, but given the uncertainties in geopolitical and tariffs you you referred to earlier, why are you optimistic? And thirdly, how much of an impact do uncertainties about The UK economy along with government fiscal approach in the long term have an effect on CTPE? Yeah. I mean, we're obviously not immune to it. I mean, we operate in the in the various economies as as everybody else does. Obviously, interest rates have gone up, although they're coming down a bit now, you know, and so the the cost of of capital has gone up.
50:32 And therefore, you have to be really sure
50:35 that you'll make an adequate return in the investments. You know, there can be adjustment... Adjustments in pricing that come through, and we've seen a bit of that. And, you know, that is an opportunity. I mean, we we try and invest in businesses where there is a growth dynamic, which is not directly or closely linked to economic performance. So looking for trends that will continue even if the economy is sluggish or even in recession. And, I mean, you can see that in our track record. I mean, we've been going through a number of financial crises and things, and most of the time, we continue to grow quite well through that. And that's because of the, you know, the focus of the private equity managers that we back. You know, they're finding
51:31 strongly growing companies. They're not overpaying. They don't have to deploy capital into those companies if they don't want to. They can quite easily sit and wait. One of the strongly observable features is that private equity deals that are done either during or in the immediate aftermath of an economic slowdown or recession tend to make better returns than those that are done, you know, before that. You could have a few percentage points extra return. And so I wouldn't be surprised if if that's what we saw over, you know, now and over the next year or two. So that is, you know, that is an observation that's based on experience. So I'm pretty sure that that will happen.
52:20 Either the private equity model, which is all about aligning interest between the investors and the the management of the companies, is very strong. It's a model where capital is provided with expertise in a way that, you know, most asset classes, they just they just get capital. You don't necessarily get expertise
52:42 in the in the investee companies. And that has proved itself really powerful. I mean, it's no accident that the strongest performing investment trusts over, you know, the long term are private equity ones. You know, we... We're one of them, but there are others as well that are up there. And it... It's because they're looking for secular growth, looking for companies that can grow,
53:14 you know, despite rather than because of the economic growth. But, you know, we've gotta watch all that stuff carefully because interest rates have gone up. Obviously, we're investing in management buyouts. There's a significant amount of debt in the capital structure of the underlying businesses. You know, if they are over geared and they don't do very well, you can lose everything in terms of the equity, and that does happen occasionally. I mean, that is one of the inherent risks that I was mentioning earlier on. So that's why we're really careful with who who we invest with, which companies we invest with, and we make sure we don't over concentrate the portfolio and it and it retains that diversification, which is a is a real strength. And we, you know, we can demonstrate that if you look back at the history.
54:02 Lovely. Covers that. Yeah. I think we we did cover that. We're getting close to the hour. We've maybe got a chance for one or two further questions before we wrap. If there are any questions we haven't gone to, we will post a response on on the IMC website so you can look for that a bit later on. But next question, you have 5% which are pre 2,014 investments.
54:23 Are these really zombie companies which are worth very little? No. Because if there were zombie companies, they wouldn't actually... They wouldn't show up on that analysis. You know, if it was zombie companies, they would be down at zero. There are some companies that are at zero and which are still, you know, still alive if you like. The investments are still current. It may be that they're just... The the equity value is kind of crushed by a layer of debt above it, but that isn't necessarily a permanent situation. A lot of these companies that have been in the portfolio for a long time can have a sort of late period flourishing where, you know, the original investment thesis has not played out the way that was expected. It's probably taken longer. It may have actually failed, and they may have a, you know, a subsequent investment thesis and even a subsequent one to that.
55:22 Businesses are reoriented, new management, and, you know, you could still make an adequate return. Obviously, the longer it is in the portfolio, the the... You know, all things being equal, the return is going to come down. But there are businesses which do recover, you know, quite quite late in the day. And interesting, we did an analysis on this because this is the sort of question we get quite often. Everyone says, oh, that old stuff must all be dross. And then we've looked at, you know, where the old stuff is then subsequently exited. The the returns are are quite reasonable. They're not brilliant. I mean, I think from memory, when we looked at the really old ones that had exited, on average, they were achieving around about a 20% IRR, which is a bit less less than our, you know, usual target of 25% plus, but it's not bad.
56:15 So it is wrong to think that that sort of stub, if you think... If you like, is is all rubbish. It's not.
56:23 Lovely. Can the current dividends be paid out at the current level over the next five to ten years is the question? Will be maintained at the current level over the next five to ten years. But we are sustainable. Yeah. Well, we expect it to grow. It will grow in line with NAV, and we expect the NAV to grow substantially over the next five to ten years so that the, you know, the the current dividend level will not go down. It will go up as soon as NAV growth resumes, which hopefully will be soon. You'll start to see the, dividend, grow, and it will grow in tandem with the NAV.
57:02 It's set at a level that we are sure that under any foreseeable circumstances, we can maintain it. So we believe the dividend is safe, and it will grow nicely from here. Lovely. I think final question for the moment. With the push towards private assets by the UK government, are you approaching smaller UK pension funds? Well, we have some pension funds who are already in our shareholder base. We've got several actually. We always have had. And in fact, you know, the... I would say the more sophisticated pension funds regard a position in in our shares is actually, you know, a a significant part of their private assets allocation.
57:54 And it has the advantage to them that they can flex it, you know, they can increase it or decrease it depending on the overall size of their portfolios or of what they're feeling about the asset class. So
58:04 this company is a good investment for a for a small and medium sized pension fund, and indeed, we have several in the in the shareholder base. So I... You know, the UK government is encouraging pension funds to invest into UK UK private equity. I think that's a good thing. I think it's
58:26 highly sensible recommendation. We have over 40% of our portfolio in The UK, which is more than most of our peers, most of whom are... Have got the portfolio spread all around the world. And so if you want to put more money into UK private equity quickly, efficiently, and with somebody that has a good track record, they should buy our shares. So I should maybe get Rachel Reeves to make that point next time she's speaking up in public about this. I think it's just come up that she's gonna have a chat with us all on... In November. Anyway, Anyway, we'll leave it there. Thank you very much, everyone, for your questions. We got through as many as possible. We will answer the rest online. We will have another update in about three months' time. We like to do these roughly quarterly.
59:12 But if you can give us your final comments, Hamish, and then we'll wrap up. Well, thanks very much, everybody, for for listening. Thanks for your questions. Thanks for your support as shareholders. Obviously, we've had a quiet period recently, but I hope from what I've explained, you'll believe that we are gonna have a better period coming up. The deal flow is is very good. There are lots of good companies out there. Realizations are still happening. We expect there'll be a reasonable pickup in the in the second half, and realizations do tend to drive growth in net asset value because they're happening at a premium to the carrying value. They basically are a good indicator of of of confidence, and confidence creates value in this sector.
1:00:04 So I would encourage you all to stick with it. I know the discount can be a bit irritating, but the other side of it is it does provide a great opportunity. And as I always say to people who are investing in private equity, you know, do it for the long term and do it regularly. And after a few years, you'll look back at your portfolio, and, hopefully, you'll you'll see a very substantial gain has been created. So thanks for your support, and I look forward to having further discussion with you in a few months time.
1:00:43 Well, that's great. Hamish, Peter, thank you very much for updating investors today. Could I please ask investors not to close the session as you now be automatically redirected to provide your feedback, and all the management team can better understand your views and expectations. Apart from management team of CT PRIVATE EQUITY TRUST PLC, we'd like to thank you for attending today's presentation, and good morning to you all.
Follow CT Private Equity Trust PLC into a list and get an email when it puts out news.
Fund Manager at CT PRIVATE EQUITY TRUST PLC
Investment Trust Sales Manager at CT PRIVATE EQUITY TRUST PLC